Off-label use & aggressive public relations • Treating depression with botox
Off-label drug marketing: Who will decide what’s “truthful” when the evidence can’t be trusted?
Coverage of Amarin off-label promotion agreement should have acknowledged deadly history of such marketing
Harvard’s Jerry Avorn warns against FDA loosening off-label marketing restrictions
More Pfizer Pfun